Study of DA-9801 to Treat Diabetic Neuropathy

Clinical trial NCT01822925 · COMPLETED

Trial details

NCT number: NCT01822925
Sponsor: NeuroBo Pharmaceuticals Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Diabetic Neuropathy

Start date: 2013-11-01
Primary completion: 2015-01-01
Enrollment: 128

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.